<SEC-DOCUMENT>0001193125-18-086159.txt : 20180319
<SEC-HEADER>0001193125-18-086159.hdr.sgml : 20180319
<ACCEPTANCE-DATETIME>20180316190156
ACCESSION NUMBER:		0001193125-18-086159
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180316
FILED AS OF DATE:		20180319
DATE AS OF CHANGE:		20180316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DBV Technologies S.A.
		CENTRAL INDEX KEY:			0001613780
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36697
		FILM NUMBER:		18697075

	BUSINESS ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
		BUSINESS PHONE:		33(0)155427878

	MAIL ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d553859d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES SECURITIES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">6-K</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13a-16</FONT> OR <FONT STYLE="white-space:nowrap">15d-16</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the Month of March 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number: <FONT STYLE="white-space:nowrap">001-36697</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>DBV TECHNOLOGIES S.A. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>92120 Montrouge France </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files
or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT STYLE="white-space:nowrap">40-F:</FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#9746;&nbsp;Form <FONT STYLE="white-space:nowrap">20-F&nbsp;&nbsp;&nbsp;&nbsp;&#9744;&nbsp;Form</FONT> <FONT STYLE="white-space:nowrap">40-F</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&#9744; </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT LIST </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:25.30pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated March&nbsp;16, 2018.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>DBV TECHNOLOGIES S.A.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: March&nbsp;16, 2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ David Schilansky</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Schilansky</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Deputy Chief Executive Officer</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g553859g04k91.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>DBV Technologies Announces Filing of 2017 &#147;Document de R&eacute;f&eacute;rence&#148; and 2017 Annual Report on Form
<FONT STYLE="white-space:nowrap">20-F</FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies (Euronext: DBV &#150; ISIN: FR0010417345&#151;Nasdaq Stock Market: DBVT) today
announced the filing of its 2017 Annual Report &#147;Document de R&eacute;f&eacute;rence&#148; for the year ended December&nbsp;31, 2017 with the French market authority &#147;Autorit&eacute; des March&eacute;s Financiers&#148; (AMF) and the filing
of its Annual Report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for the year ended December&nbsp;31, 2017, with the U.S. Securities and Exchange Commission (SEC). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These documents can be accessed on the Investors&nbsp;&amp; Media section of the Company&#146;s website at
<FONT STYLE="white-space:nowrap">www.dbv-technologies.com.</FONT> In addition, the &#147;Document de R&eacute;f&eacute;rence&#148; is available on the AMF&#146;s website at <FONT STYLE="white-space:nowrap">www.amf-france.org</FONT> and the Form <FONT
STYLE="white-space:nowrap">20-F</FONT> is available on the SEC&#146;s website at www.sec.gov. Printed copies of the &#147;Document de R&eacute;f&eacute;rence&#148; are available at the Company&#146;s headquarters and registered office located at <FONT
STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette 92120 Montrouge, France. Any shareholder can request a printed copy of the Form <FONT STYLE="white-space:nowrap">20-F,</FONT> free of charge, upon request. Requests should be
directed to DBV Technologies, Attn: Investor Relations, <FONT STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette 92120 Montrouge, France. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About DBV Technologies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies is developing
Viaskin<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, a proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, DBV&#146;s method of delivering biologically active compounds to the immune system through intact skin. With this new class of self-administered and
<FONT STYLE="white-space:nowrap">non-invasive</FONT> product candidates, the company is dedicated to safely transforming the care of food allergic patients, for whom there are no approved treatments. DBV&#146;s food allergies programs include
ongoing clinical trials of Viaskin Peanut and Viaskin Milk, and preclinical development of Viaskin Egg. DBV is also pursuing a human <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> clinical study of
Viaskin Milk for the treatment of Eosinophilic Esophagitis, and exploring potential applications of its platform in vaccines and other immune diseases. DBV Technologies has global headquarters in Montrouge, France and New York, NY. Company shares
are traded on segment A of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345), part of the SBF120 index, and traded on the Nasdaq Global Select Market in the form of American Depositary Shares (each representing
<FONT STYLE="white-space:nowrap">one-half</FONT> of one ordinary share) (Ticker: DBVT). For more information on DBV Technologies, please visit our website: <FONT STYLE="white-space:nowrap">www.dbv-technologies.com</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Investor Relations Contact </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sara Blum Sherman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Director, Investor Relations&nbsp;&amp; Strategy </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1&nbsp;212-271-0740</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">sara.sherman@dbv-technologies.com</FONT></U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DBV Media Contact </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Roberta Di Giorgio </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Director, Corporate Communications </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">+1&nbsp;917-612-2861</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">roberta.digiorgio@dbv-technologies.com</FONT></U> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g553859g50v93.jpg" ALT="LOGO">
 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g553859g04k91.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g553859g04k91.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /**]$X@H * "@ I@% !2 * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MXK_WRW^%']IP_E_K[@_LU_S?U]X?\*W\0?\ /%?^^6_PH_M.'\O]?<']FO\
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MQ7_OEO\ "C^TX?R_U]P?V:_YOZ^\/^%;^(/^>*_]\M_A1_:</Y?Z^X/[-?\
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M;^OO#_A6_B#_ )XK_P!\M_A1_:</Y?Z^X/[-?\W]?>'_  K?Q!_SQ7_OEO\
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M_P!?<']FO^;^OO#_ (5OX@_YXK_WRW^%']IP_E_K[@_LU_S?U]X?\*W\0?\
M/%?^^6_PH_M.'\O]?<']FO\ F_K[P_X5OX@_YXK_ -\M_A1_:</Y?Z^X/[-?
M\W]?>?5&*LY@Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &
M* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #
M% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !
MB@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@
MQ0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ H * "@ H *!!0,* "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * (YIX[>(RRN$1>I-"U#8S!-?ZA\T)%I;]F899A5M*)%VRNUO9!B)-9FW=\
M3#C_  I_(5O,L)#>PH)+*]%U'_=<YS^/_P"JI5MF4[K4MV5^EV&7:8YDX>-N
MHI-6!.Y<I%!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M9(WEQLWH": , !T\.QH&Q)<289O4Y_\ K5I]HSZ&^D:Q1K&@PJC  ["LS0?0
M GX4 9<:B'7YH@/W<\6\CWSC_'\ZKH3:S':(=MG)".D,K(/Y_P!:&-&G4C"@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MKXEBN[J.!--OU#L )&APH]R<U<J+BKMHRABU.22B]?(VZP.P* "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MD"@!00>AH * "@"I'JFGRW[V$=];O>(,M LJF1?JN<CJ*=G:XKK8MTAA0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M$8QM'X=*+L=A+73[*P#"SLX+<-U$483/Y4-M[BM86ZL+.^4+=VD-PJ]!+&'
M_.A-K8=B2""&VB6*")(HUZ(BA0/P%("2@ H * "@ H J:I?QZ5I-YJ$PS':P
MO,P'<*"<?I32N[";LCS[P7X0M_$MJ/%GBJ)=0O\ 4,O%%+S%#%GY0%Z=.>?Y
MYSM.?+[L3.,;^\Q_CGP'8V>@WVL>'(5TR_M[=_,6W&V.>(J=Z,O3[N>W7]%"
MHV[2'**2NA5_Y(!_W"C_ "I_\O?F'V \!>!;&X\/Z?J_B"%=3OY[=/*%R-Z0
M1 ?(BJ>/NX[=?U52;3M$(Q5KL3QKX2M_#]FWBOPO"FG:EIW[V1(1MCFCS\RL
MHXZ<_P"1APGS>[()1MJBUXUA?Q%X#L/$VEKMOK%8]2MCU(& S+^7..^T4H>[
M+E82UC='1Q^*;%_!@\3$XM/LWGD9Y!QROUS\OUK/E?-RE<RM<Q?AGI<\&@3:
MW?C_ (F.M2F[E/<*?N#Z8.?^!5=5ZV704%I<[:LBPH * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MP2=[BJ.2MRB3W3FYA$+XCRN\XSG=T'Y?TH4=[BE-NW+Y?BQYO0MVL#!/F;:
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MY&0_(5/56'/7KR:E_"-;G65F6% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0!!>65MJ%J]M=PK+"^,J?4'((]"#SF
MFG;8+7(++2++3YI)X(W,\@"M++*TKE1T&YB3CGI0VV)*Q>I#"@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
$@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g553859g50v93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g553859g50v93.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M,5T/:[MD:96N(E:% \@+@%%.<$^@X/)]#2L,9<:A96AB%S=P0^;Q'YD@7?\
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M3@HK)N7[,8RR[@"3N/4@9P3Z9&TM 2N):>$+J.Q2VNXTN?L]OY$6;QE5^5Z
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
00 4 % !0 4 % !0 4 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
